Taken together, these data indicate that liver fibrosis progression, as a consequence of NASH, is characterized by loss of restorative M-CSF-dependent liver macrophages, in line with recent observations in NASH mouse models (30). This evidence concerns the gene CSF1 and metabolic dysfunction-associated steatohepatitis.